Skip to main content
. 2019 Nov 18;20(22):5792. doi: 10.3390/ijms20225792
ASD Anti-seizure drug
AKT Protein kinase B (PKB)
APDS Activated phosphoinositide 3-kinase δ syndrome
BRRS Bannayan-Riley-Ruvalcaba-Syndrom
CLL Chronic lymphatic leukemia
CLOVES congenital lipomatous overgrowth with vascular, epidermal, and skeletal anomalies
CNS Central nervous system
CS Cowden Syndrome
FCD Focal Cortical Dysplasia
FCM Focal cortical malformation
GOF Gain of Function
GPCR G protein-coupled receptor
LOF Loss of Function
MCAP megalencephaly capillary malformation
mTOR Mammalian target of rapamycin
PI3K Phosphatidyl inositol-3-kinase
PIP2 Phosphatidylinositolbisphosphate
PK Pharmacokinetic
PROS PIK3CA-related overgrowth spectrum
PTEN Phosphatase And Tensin Homolog
RTK Receptor tyrosine kinase
SEGA Subependymal giant cell astrocytoma
TAND TSC-associated neuropsychiatric disorders
TORKi mTOR kinase inhibitor
TSC Tuberous Sclerosis Complex